Bruno Oliveira Souza e Silva | Diagnostic | Best Innovation Award

Published on by Global Diseases Research

Mr. Bruno Oliveira Souza e Silva | Diagnostic | Best Innovation Award 

Public servant | State Secretariat of Health of Minas Gerais | Brazil

Bruno Oliveira Souza e Silva is a dedicated Brazilian pharmacist and health professional with extensive experience in clinical analysis, laboratory coordination, and public health. He holds a Bachelor’s degree in Pharmacy with specialization in Clinical and Toxicological Analysis from the José do Rosário Vellano University, a Master’s degree in Health Education from UFVJM, and multiple postgraduate specializations in Chemistry, Higher Education Teaching, Environmental Health Surveillance, and Health Surveillance. Currently serving as a Clinical Analyst Pharmacist at the State Health Secretariat of Minas Gerais, he coordinates the Macrorregional Laboratory of Teófilo Otoni, overseeing diagnostic services for tuberculosis, leishmaniasis, and leprosy. His professional background also includes teaching roles at the Doctum University Center of Teófilo Otoni, where he contributes to Pharmacy, Dentistry, Nursing, and Biomedical programs. An alumnus of the EpiSUS Fundamental Program, he is also a Field Epidemiologist and member of the Technical Working Group on Clinical and Toxicological Analysis of the Regional Pharmacy Council of Minas Gerais. Bruno’s expertise spans pharmacy, biochemistry, microbiology, parasitology, and pharmacology, supported by a robust record of research and publication in disease surveillance, epidemiology, and laboratory science. His commitment to innovation and public health excellence has earned him several distinctions, including the Pharmaceutical Attitude Award (2024) and the Inova Minas Gerais Award (2021) for public policy innovation. Passionate about scientific education and health system strengthening, he continues to advance integrated approaches to laboratory diagnostics, disease prevention, and epidemiological surveillance in Brazil’s public health sector.

Profile: ORCID

Featured Publications

Tokai, B. O., & Costa, A. S. (2021). Estudo sobre a qualidade da água para consumo humano e as doenças diarreicas no Brasil. Revista Baiana de Saúde Pública, 43(4), e2979. Cited by: 3

 

Liancai Mu | Diagnostic | Best Researcher Award

Published on by Global Diseases Research

Prof. Liancai Mu | Diagnostic | Best Researcher Award

Senior Scientist | Hackensack Meridian Health | United States

Prof. Liancai Mu, M.D., Ph.D., is a Senior Scientist at the Upper Airway Research Laboratory, Center for Discovery & Innovation, Hackensack Meridian Health, with over three decades of academic and clinical experience in otolaryngology and neuroscience. His research focuses on the neuromuscular specializations of human upper airway structures and the mechanisms underlying speech, swallowing, and voice (SSV) disorders, particularly in Parkinson’s disease (PD). Mu’s pioneering work demonstrated that PD affects the peripheral nervous system of the pharynx and larynx, contributing significantly to SSV impairments, and led to the development of novel diagnostic and therapeutic approaches. He mapped the nerve supply of laryngeal, pharyngeal, soft palate, and tongue muscles using Sihler’s staining technique and identified neuromuscular compartments with specialized fibers, leading to a new theory that pharyngeal constrictors are controlled by two distinct neuromuscular systems (IX-SIL and X-FOL), now included in modern medical texts. Additionally, he developed an innovative muscle reinnervation method, “nerve-muscle-endplate grafting” (NMEG), which achieves superior functional recovery compared to traditional nerve repair. Mu has led multiple NIH R01, DOD, and Michael J. Fox Foundation-funded projects, collaborated internationally with institutions such as Mount Sinai Medical Center, Linguaflex, Inc., and the Arizona Study of Aging and Neurodegenerative Disorders, and served as a consultant for FDA-approved therapies. He has published 68 peer-reviewed articles across 22 indexed journals, accrued 2,772 citations and holds an h-index of 30, reflecting his substantial impact in neuroscience, otolaryngology, and PD research.

Profile:  Scopus

Featured Publications